Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference
CHARLESTOWN, Mass. , April 13, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq:SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 22nd Annual Needham Healthcare Conference on Thursday, April 20, 2023 at 8:00 AM ET.
Related news for (SLDB)
- Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
- Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/21/25 12:00 PM
- Solid Biosciences to Participate at Upcoming Investor Conferences
- Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference